Long term management of ulcerative colitis with Faecal Microbiota Transplantation

Marchesi, 2016, The gut microbiota and host health: a new clinical frontier, Gut, 65, 330, 10.1136/gutjnl-2015-309990 Zhang, 2014, Inflammatory bowel disease: Pathogenesis, World J Gastroenterol, 20, 91, 10.3748/wjg.v20.i1.91 Moayyedi, 2015, Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial, Gastroenterology, 149, 102, 10.1053/j.gastro.2015.04.001 Costello, 2019, Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial, J Am Med Assoc, 321, 156, 10.1001/jama.2018.20046 Paramsothy, 2017, Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial, Lancet, 389, 1218, 10.1016/S0140-6736(17)30182-4 Swidsinski, 2005, Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease, J Clin Microbiol, 43, 3380, 10.1128/JCM.43.7.3380-3389.2005 Manichanh, 2012, The gut microbiota in IBD, Nat Rev Gastroenterol Hepatol, 9, 599, 10.1038/nrgastro.2012.152 Tian, 2017, Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies, Oxid Med Cell Longev, 2017, 4535194, 10.1155/2017/4535194 Nishida, 2018, Gut microbiota in the pathogenesis of inflammatory bowel disease, Clin J Gastroenterol, 11, 1, 10.1007/s12328-017-0813-5 Knights, 2013, Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome, Gut, 62, 10.1136/gutjnl-2012-303954 Knights, 2014, Complex host genetics influence the microbiome in inflammatory bowel disease, Genome Med, 6, 10.1186/s13073-014-0107-1 Kaur, 2020, Probiotics for induction of remission in ulcerative colitis, Cochrane Database Syst Rev Iheozor-Ejiofor, 2020, Probiotics for maintenance of remission in ulcerative colitis, Cochrane Database Syst Rev Petersen, 2014, Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial, J Crohns Colitis, 8, 1498, 10.1016/j.crohns.2014.06.001 Sood, 2009, The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis, Clin Gastroenterol Hepatol, 7, 1202, 10.1016/j.cgh.2009.07.016 Basso, 2019, Microbial-based therapies in the treatment of inflammatory bowel disease – an overview of human studies, Front Pharmacol, 9, 10.3389/fphar.2018.01571 Keshteli, 2019, Diet in the pathogenesis and management of ulcerative colitis; A review of randomized controlled dietary interventions, Nutrients, 11, 10.3390/nu11071498 Hansen, 2015, Therapeutic manipulation of the microbiome in IBD: current results and future approaches, Curr Treat Options Gastroenterol, 13, 105, 10.1007/s11938-014-0042-7 Sood, 2019, Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis, Int Res, 17, 78 Khoruts, 2016, Understanding the mechanisms of faecal microbiota transplantation, Nat Rev Gastroenterol Hepatol, 13, 508, 10.1038/nrgastro.2016.98 Burrello, 2018, Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells, Nat Commun, 9, 5184, 10.1038/s41467-018-07359-8 Ekmekciu, 2017, Immune responses to broad-spectrum antibiotic treatment and fecal microbiota transplantation in mice, Front Immunol, 8, 397, 10.3389/fimmu.2017.00397 Ekmekciu, 2017, Fecal microbiota transplantation, commensal Escherichia coli and lactobacillus johnsonii strains differentially restore intestinal and systemic adaptive immune cell populations following broad-spectrum antibiotic treatment, Front Microbiol, 8, 2430, 10.3389/fmicb.2017.02430 Rossen, 2015, Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis, Gastroenterology, 149, 110, 10.1053/j.gastro.2015.03.045 Imdad, 2018, Fecal transplantation for treatment of inflammatory bowel disease, Cochrane Database Syst Rev, 11 Sood, 2019, Role of faecal microbiota transplantation for maintenance of remission in patients with ulcerative colitis: a pilot study, J Crohns Colitis, 13, 1311, 10.1093/ecco-jcc/jjz060 Li, 2020, Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis, Eur J Gastroenterol Hepatol, 32, 955, 10.1097/MEG.0000000000001725 Staley, 2019, Durable long-term bacterial engraftment following encapsulated fecal microbiota transplantation to treat Clostridium difficile infection, mBio, 10, 10.1128/mBio.01586-19 Jalanka, 2016, Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection, BMC Med, 14, 155, 10.1186/s12916-016-0698-z Angelberger, 2013, Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation, Am J Gastroenterol, 108, 1620, 10.1038/ajg.2013.257 Li, 2020, Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes, Clin Transl Gastroenterol, 11, 10.14309/ctg.0000000000000224 Berg, 2015, Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?, Expet Rev Gastroenterol Hepatol, 9, 781, 10.1586/17474124.2015.1013031 Nishikawa, 2009, Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis, Scand J Gastroenterol, 44, 180, 10.1080/00365520802433231 Clooney, 2020, Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study, Gut, 10.1136/gutjnl-2020-321106 Walujkar, 2018, Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis, World J Microbiol Biotechnol, 34, 76, 10.1007/s11274-018-2449-0 Moayyedi, 2018, Update on fecal microbiota transplantation in patients with inflammatory bowel disease, Gastroenterol Hepatol, 14, 319 Tian, 2019, Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study, BMC Gastroenterol, 19, 116, 10.1186/s12876-019-1010-4 Quraishi, 2020, OP09 Immunomodulatory mechanisms of faecal microbiota transplantation are associated with clinical response in ulcerative colitis: early results from STOP-Colitis, J Crohns Colitis, 14, 10.1093/ecco-jcc/jjz203.008 Chu, 2017, Host gene–microbiome interactions: molecular mechanisms in inflammatory bowel disease, Genome Med, 9, 10.1186/s13073-017-0459-4 Hall, 2017, Human genetic variation and the gut microbiome in disease, Nat Rev Genet, 18, 690, 10.1038/nrg.2017.63 Ananthakrishnan, 2018, Environmental triggers in IBD: a review of progress and evidence, Nat Rev Gastroenterol Hepatol, 15, 39, 10.1038/nrgastro.2017.136 Phillips, 2009, Gut reaction: environmental effects on the human microbiota, Environ Health Perspect, 117, A198, 10.1289/ehp.117-a198 Vedamurthy, 2019, Influence of environmental factors in the development and outcomes of inflammatory bowel disease, Gastroenterol Hepatol, 15, 72 Sekhon, 2017, Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework, BMC Health Serv Res, 17, 88, 10.1186/s12913-017-2031-8 Ding, 2019, Long-term safety and efficacy of fecal microbiota transplant in active ulcerative colitis, Drug Saf, 42, 869, 10.1007/s40264-019-00809-2 Zhang, 2019, Evolution of fecal microbiota transplantation in methodology and ethical issues, Curr Opin Pharmacol, 49, 11, 10.1016/j.coph.2019.04.004 Steube, 2019, Long-term multidonor faecal microbiota transfer by oral capsules for active ulcerative colitis, J Crohns Colitis, 13, 1480, 10.1093/ecco-jcc/jjz073 MD HD, 2020 FMT for remission of active ulcerative colitis in adults - full text view - ClinicalTrials.gov. Accessed August 23, 2020. https://clinicaltrials.gov/ct2/show/NCT04202211. Henn, 2020, A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis, Gastroenterology Paramsothy, 2017, Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis, J Crohns Colitis, 11, 1180, 10.1093/ecco-jcc/jjx063 DeFilipp, 2019, Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant, N Engl J Med, 381, 2043, 10.1056/NEJMoa1910437 Quraishi, 2017, Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection, Aliment Pharmacol Ther, 46, 479, 10.1111/apt.14201 Li, 2016, Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection, Aliment Pharmacol Ther, 43, 445, 10.1111/apt.13492 Sood, 2020, Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study), J Gastroenterol Hepatol, 35, 418, 10.1111/jgh.14829 Mahajan, 2020, Incidental benefits after fecal microbiota transplant for ulcerative colitis, Int Res, 18, 337 Smillie, 2018, Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation, Cell Host Microbe, 23, 229, 10.1016/j.chom.2018.01.003 Li, 2016, Durable coexistence of donor and recipient strains after fecal microbiota transplantation, Science, 352, 586, 10.1126/science.aad8852 Wu, 2011, Linking long-term dietary patterns with gut microbial enterotypes, Science, 334, 105, 10.1126/science.1208344 Nowak, 2012, Tryptophan hydroxylase-1 regulates immune tolerance and inflammation, J Exp Med, 209, 2127, 10.1084/jem.20120408 Mentella, 2020, Nutrition, IBD and gut microbiota: a review, Nutrients, 12, 10.3390/nu12040944